Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter September 17, 2019

Definition of analytical quality specifications for serum total folate measurements using a simulation outcome-based model

  • Simona Ferraro EMAIL logo , Andrew W. Lyon , Federica Braga and Mauro Panteghini
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Ferraro S, Panzeri A, Panteghini M. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays, and health outcomes. Clin Chem Lab Med 2017;55:1262–75.10.1515/cclm-2016-0804Search in Google Scholar PubMed

2. World Health Organization. Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva: World Health Organization, 2015. apps.who.int/iris/bitstream/10665/…/9789241549042_eng.pdf. Accessed May 2019.Search in Google Scholar

3. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;4:CD004514.10.1002/14651858.CD004514.pub2Search in Google Scholar PubMed

4. Chen MY, Rose CE, Qi YP, Williams JL, Yeung LF, Berry RJ, et al. Defining the plasma folate concentration associated with the red blood cell folate concentration threshold for optimal neural tube defects prevention: a population-based, randomized trial of folic acid supplementation. Am J Clin Nutr 2019;109: 1452–61.10.1093/ajcn/nqz027Search in Google Scholar PubMed PubMed Central

5. Ferraro S, Panteghini M. Folate and vitamin B12 assays after recalibration to the WHO International Standard 03/178: making the interpretation as simple as possible, but not simpler. Clin Chem Lab Med 2019;57:1112–4.10.1515/cclm-2019-0050Search in Google Scholar PubMed

6. Ferraro S, Panteghini M. Defining the plasma folate concentration for optimal neural tube defects prevention cannot ignore the impact of the employed methodology. Am J Clin Nutr 2019. Accepted for publication.10.1093/ajcn/nqz128Search in Google Scholar PubMed

7. Ceriotti F, Fernandez-Calle P, Klee GG, Nordin G, Sandberg S, Streichert T, et al. Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clin Chem Lab Med 2017;55: 189–94.10.1515/cclm-2017-0772Search in Google Scholar PubMed

8. Ferraro S, Braga F, Panteghini M. Laboratory medicine in the new healthcare environment. Clin Chem Lab Med 2016;54: 523–33.10.1515/cclm-2015-0803Search in Google Scholar PubMed

9. Lyon AW, Kavsak PA, Lyon OA, Worster A, Lyon ME. Simulation models of misclassification error for single thresholds of high sensitivity cardiac troponin I due to assay bias and imprecision. Clin Chem 2017;63:585–92.10.1373/clinchem.2016.265058Search in Google Scholar PubMed

10. Godoy A, Tabares AH. Prevalence of low folate deficiency after wheat flour supplementation – should we still measure serum folate? Hematol Transfus Cell Ther 2018;40:305–9.10.1016/j.htct.2018.03.007Search in Google Scholar PubMed PubMed Central


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2019-0695).


Received: 2019-07-09
Accepted: 2019-08-26
Published Online: 2019-09-17
Published in Print: 2020-02-25

©2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 8.5.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2019-0695/html
Scroll to top button